Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mebendazole disrupts stromal desmoplasia and tumorigenesis in two models of pancreatic cancer
Tara Williamson, Michelle Carvalho de Abreu, Dimitri G. Trembath, et al.
Oncotarget (2021) Vol. 12, Iss. 14, pp. 1326-1338
Open Access | Times Cited: 24

Showing 24 citing articles:

Emerging Perspectives on the Antiparasitic Mebendazole as a Repurposed Drug for the Treatment of Brain Cancers
Daniela Meco, Giorgio Attinà, Stefano Mastrangelo, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1334-1334
Open Access | Times Cited: 31
Breaking the stromal barrier in pancreatic cancer: Advances and challenges
Mohana Chakkera, Jeremy B. Foote, Batoul Farran, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1879, Iss. 1, pp. 189065-189065
Closed Access | Times Cited: 14
Mebendazole preferentially inhibits cilia formation and exerts anticancer activity by synergistically augmenting DNA damage
Juyeon Hong, Keun Yeong Kwon, Dong Gil Jang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116434-116434
Open Access | Times Cited: 4
Functional designed S-doped FeWO4 hybrid for efficient mebendazole electro-oxidation and photodegradation of Methylene Blue
S. Munusamy, G. Gnanamoorthy, Muthamizh Selvamani, et al.
Materials Science and Engineering B (2024) Vol. 309, pp. 117677-117677
Closed Access | Times Cited: 4
Antidiabetics, Anthelmintics, Statins, and Beta-Blockers as Co-Adjuvant Drugs in Cancer Therapy
Laurenţia Galeş, Leyla Forsea, Diana M. Mitrea, et al.
Medicina (2022) Vol. 58, Iss. 9, pp. 1239-1239
Open Access | Times Cited: 18
Repurposing of Mebendazole as an Anticancer Agent: A Review
Vikram Nimbalkar, Sakshi A. Bhongal, Nikita R. Dhage, et al.
Research Journal of Pharmacy and Technology (2025), pp. 1619-1624
Closed Access
Mebendazole; from an anti-parasitic drug to a promising candidate for drug repurposing in colorectal cancer
Sahar K. Hegazy, Gamal A. El-Azab, Fatma Zakaria, et al.
Life Sciences (2022) Vol. 299, pp. 120536-120536
Closed Access | Times Cited: 16
Mebendazole Treatment Disrupts the Transcriptional Activity of Hypoxia-Inducible Factors 1 and 2 in Breast Cancer Cells
Natalie Joe, Yuanfeng Wang, Harsh Oza, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1330-1330
Open Access | Times Cited: 9
Patient-derived tumor models are attractive tools to repurpose drugs for ovarian cancer treatment: Pre-clinical updates
Magdalena Cybula, Magdalena Bieniasz
Oncotarget (2022) Vol. 13, Iss. 1, pp. 553-575
Open Access | Times Cited: 14
Mebendazole, an anti-helminth drug, suppresses inflammation, oxidative stress and injury in a mouse model of ulcerative colitis
Moein Eskandari, Fereshteh Asgharzadeh, Mohammad Mostafa Askarnia-faal, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 14
Mebendazole prevents distant organ metastases in part by decreasing ITGβ4 expression and cancer stemness
Natalie Joe, Inês Godet, Nubaira Milki, et al.
Breast Cancer Research (2022) Vol. 24, Iss. 1
Open Access | Times Cited: 14
Mebendazole targets essential proteins in glucose metabolism leading gastric cancer cells to death
Emerson Lucena da Silva, Felipe Pantoja Mesquita, Dyane Rocha Aragão, et al.
Toxicology and Applied Pharmacology (2023) Vol. 475, pp. 116630-116630
Closed Access | Times Cited: 8
Mebendazolium mesylate anhydride salt: rational design based on supramolecular assembly, synthesis, and solid-state characterization
Eduardo L. Gutiérrez, Agustín A. Godoy, Elena V. Brusau, et al.
RSC Advances (2024) Vol. 14, Iss. 1, pp. 181-192
Open Access | Times Cited: 2
Computational drug discovery approaches identify mebendazole as a candidate treatment for autosomal dominant polycystic kidney disease
Philip W. Brownjohn, Azedine Zoufir, Daniel J. O’Donovan, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Pancreatic Ductal Adenocarcinoma Cortical Mechanics and Clinical Implications
Shantel Angstadt, Qingfeng Zhu, Elizabeth M. Jaffee, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 11
Mebendazole Impedes the Proliferation and Migration of Pancreatic Cancer Cells through SK1 Inhibition Dependent Pathway
Khem Raj Limbu, Rashmi Bhandari Chhetri, Yoon Sin Oh, et al.
Molecules (2022) Vol. 27, Iss. 23, pp. 8127-8127
Open Access | Times Cited: 10
Drug Repurposing in Pediatric Brain Tumors: Posterior Fossa Ependymoma and Diffuse Midline Glioma under the Looking Glass
Tiziana Servidei, Alessandro Sgambato, Donatella Lucchetti, et al.
Frontiers in Bioscience-Landmark (2023) Vol. 28, Iss. 4
Open Access | Times Cited: 5
Evaluation of novel anti-CEACAM6 antibody-based conjugates for radioimmunotheranostics of pancreatic ductal adenocarcinoma
Yanyan Kong, Fang Xie, Zhengwei Zhang, et al.
European Radiology (2023) Vol. 33, Iss. 10, pp. 7077-7088
Closed Access | Times Cited: 5
Repurposing antiparasitic drugs for the treatment of other diseases
Naser‐Aldin Lashgari, Nazanin Momeni Roudsari, Danial Ahmadvand, et al.
Elsevier eBooks (2024), pp. 161-261
Closed Access | Times Cited: 1
Detection of common pathogenesis of rheumatoid arthritis and atherosclerosis via microarray data analysis
Fan Xu, Linfeng Xie, Jian He, et al.
Heliyon (2024) Vol. 10, Iss. 8, pp. e28029-e28029
Open Access | Times Cited: 1
Maduramicin-guided nanotherapy: A polymeric micelles for targeted drug delivery in canine mammary tumors
Xinhao Song, Mengjuan Lin, Fang Tian, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 170, pp. 116062-116062
Open Access | Times Cited: 3
Cyclodextrin Dispersion of Mebendazole and Flubendazole Improves In Vitro Antiproliferative Activity
Daliana Minda, Alexandra Mioc, Christian Banciu, et al.
Processes (2021) Vol. 9, Iss. 12, pp. 2185-2185
Open Access | Times Cited: 5
Exploiting the molecular subtypes and genetic landscape in pancreatic cancer: the quest to find effective drugs
Nnenna Elebo, Ebtesam A. Abdel-Shafy, Stefano Cacciatore, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 1
Testicular immunity
Shuyun Li, Sudeep Kumar, Xiaowei Gu, et al.
Molecular Aspects of Medicine (2024) Vol. 100, pp. 101323-101323
Closed Access
Page 1

Scroll to top